Unraveling the Enigma of Melanoma Brain Metastasis: New Molecular Insights and Therapeutic Directions
Open Access
- 20 February 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 2019
Abstract
Melanoma, a highly aggressive and metastatic cancer, poses significant challenges due to its propensity to spread to distant organs, with brain metastasis representing a particularly devastating complication. This review synthesizes preclinical and clinical evidence on the molecular, cellular, and microenvironmental mechanisms driving melanoma metastasis, emphasizing mechanisms of blood–brain barrier traversal, tumor-stroma co-option, and brain-specific genomic and transcriptional programs. We summarize advances in therapeutic strategies to combat melanoma brain metastasis including novel small molecules, immunotherapies, and combination approaches tailored for brain metastases. The review also highlights the immunological landscape of the brain, translational models, and multidisciplinary clinical management strategies. Finally, we identify critical research gaps, including the need for brain metastasis-specific clinical trials, AI-driven predictive models, and preventive strategies, to guide future efforts in improving outcomes for patients with melanoma brain metastasis.Keywords
All Related Versions
Funding Information
- National Cancer Institute (R01 CA121118)
This publication has 196 references indexed in Scilit:
- Modeling anti-tumor immune responses using patient-derived melanoma organoidsCancer Immunology, Immunotherapy, 2025
- AI‐Enhanced Predictive Imaging in Precision Medicine: Advancing Diagnostic Accuracy and Personalized TreatmentiRADIOLOGY, 2025
- Melanoma Treatments and Mortality Rate Trends in the US, 1975 to 2019JAMA Network Open, 2022
- Role of radiation oncology in modern multidisciplinary cancer treatmentMolecular Oncology, 2020
- Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case seriesCancer, 2019
- Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapiesCancer, 2017
- Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncologyJournal of Cancer Research and Clinical Oncology, 2013
- NRAS mutation status is an independent prognostic factor in metastatic melanomaCancer, 2011
- Prognostic factors for survival in melanoma patients with brain metastasesCancer, 2010
- Targeting cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4)Cancer, 2007